NO20053681L - Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav - Google Patents

Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav

Info

Publication number
NO20053681L
NO20053681L NO20053681A NO20053681A NO20053681L NO 20053681 L NO20053681 L NO 20053681L NO 20053681 A NO20053681 A NO 20053681A NO 20053681 A NO20053681 A NO 20053681A NO 20053681 L NO20053681 L NO 20053681L
Authority
NO
Norway
Prior art keywords
dispersion
granules
crystals
preparation
chewable
Prior art date
Application number
NO20053681A
Other languages
English (en)
Other versions
NO339528B1 (no
Inventor
Marie-Madeleine Bohn
Julien Meissonnier
Fabrice Rose
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of NO20053681L publication Critical patent/NO20053681L/no
Publication of NO339528B1 publication Critical patent/NO339528B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Foreliggende oppfinnelse omhandler en dispersjon av krystaller eller granuler av aktiv substans i et lipofilt vehikkel, krystallene eller granulene er belagt med et belegg for smaksmaskerende formål. Oppfinnelsen omhandler også enhetsdoseringsformer og fortrinnsvis tyggbare eller hurtigoppløsende myke gelatinkapsler fylt med dispersjonen så vel som fremgangsmåte for fremstilling derav.
NO20053681A 2003-01-24 2005-07-29 Dispersjon av krystaller eller granuler av aktiv substans i en lipofil vehikkel, tyggbare myke kapsler og fremgangsmåte for fremstilling derav. NO339528B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300824A FR2850275B1 (fr) 2003-01-24 2003-01-24 Capsules molles a macher contenant une substance active a gout masque
PCT/US2004/001463 WO2004066925A2 (en) 2003-01-24 2004-01-21 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same

Publications (2)

Publication Number Publication Date
NO20053681L true NO20053681L (no) 2005-08-23
NO339528B1 NO339528B1 (no) 2016-12-27

Family

ID=32669215

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053681A NO339528B1 (no) 2003-01-24 2005-07-29 Dispersjon av krystaller eller granuler av aktiv substans i en lipofil vehikkel, tyggbare myke kapsler og fremgangsmåte for fremstilling derav.

Country Status (19)

Country Link
EP (1) EP1592402B1 (no)
JP (1) JP5371187B2 (no)
CN (2) CN1741787A (no)
AR (1) AR042902A1 (no)
AU (1) AU2004207498B2 (no)
BR (1) BRPI0406913B8 (no)
CA (1) CA2512988C (no)
DK (1) DK1592402T3 (no)
ES (1) ES2415660T3 (no)
FR (1) FR2850275B1 (no)
HK (1) HK1082659A1 (no)
MX (1) MXPA05007683A (no)
NO (1) NO339528B1 (no)
NZ (1) NZ541753A (no)
PT (1) PT1592402E (no)
RU (1) RU2362546C2 (no)
SI (1) SI1592402T1 (no)
UA (1) UA84140C2 (no)
WO (1) WO2004066925A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013944A1 (en) * 2003-08-11 2005-02-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
CA2691995C (en) * 2007-07-19 2016-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
CA2706272C (en) * 2010-06-03 2020-05-05 Accucaps Industries Limited Multi phase soft gel capsules, apparatus and method thereof
CA2706270C (en) * 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
AU2012214939B2 (en) * 2011-02-11 2016-11-17 Ctc Bio, Inc. Sildenafil-free base-containing film preparation and method for producing same
CA3023121A1 (en) * 2011-04-11 2012-10-18 Vitux Group As Oral pharmaceutical dispersion compositions
EP2699267A4 (en) * 2011-04-18 2014-11-12 Lipidor Ab LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE
CN102241782B (zh) * 2011-05-18 2013-01-30 清华大学 一种淀粉乙酸酯的制备方法及其在去除水中硝酸盐的应用
CN102813275B (zh) 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant
ES2972665T3 (es) * 2015-03-26 2024-06-13 Patheon Softgels Inc Cápsulas liquisoft
SI3429559T1 (sl) 2016-03-15 2022-11-30 Acer Therapeutics Inc. Okusni sestavki, ki vključujejo natrijev fenilbutirat, in njihove uporabe
JP6942342B2 (ja) * 2016-11-02 2021-09-29 富士カプセル株式会社 ソフトカプセル皮膜
JP2018121699A (ja) * 2017-01-30 2018-08-09 株式会社アクレス クリルオイルを充填したカプセル剤
CN107373744B (zh) * 2017-07-13 2018-11-09 云南中烟工业有限责任公司 一种维生素c微胶囊的制备方法及其在卷烟中的应用
CN108524464A (zh) * 2018-05-17 2018-09-14 安士制药（中山）有限公司 一种西甲硅油软胶囊的制备方法
AU2020223894A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising Ibuprofen
WO2020169991A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
EP3927314B1 (en) * 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623557D0 (en) 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
CH677606A5 (no) 1988-07-12 1991-06-14 Aesculapius Pharma Sa
US4975465A (en) 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
CA2063141C (en) 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5262179A (en) 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
ATE121619T1 (de) 1990-04-11 1995-05-15 Upjohn Co Verfahren zum geschmacksabdecken von ibuprofen.
JP3157233B2 (ja) * 1991-11-22 2001-04-16 エーザイ株式会社 水溶性薬物を含有した軟カプセル剤
JP3136310B2 (ja) * 1992-02-26 2001-02-19 東洋カプセル株式会社 咀嚼服用に適した担体
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
DE69313865T2 (de) * 1992-10-16 1998-02-12 Glaxo Group Ltd Geschmacksmaskierende zusammensetzungen von ranitidin
GB9313329D0 (en) * 1993-06-28 1993-08-11 Scherer Ltd R P Softgel capsule shell compositions
US5466865A (en) 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
EP1163901B1 (en) * 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20030096791A1 (en) * 2001-05-31 2003-05-22 Cima Labs Inc. Taste masking of highly water-soluble drugs

Also Published As

Publication number Publication date
MXPA05007683A (es) 2005-09-30
EP1592402A2 (en) 2005-11-09
FR2850275A1 (fr) 2004-07-30
NO339528B1 (no) 2016-12-27
FR2850275B1 (fr) 2005-04-08
AU2004207498A1 (en) 2004-08-12
CA2512988C (en) 2015-11-10
HK1082659A1 (en) 2006-06-16
WO2004066925A3 (en) 2004-10-28
EP1592402A4 (en) 2009-01-14
BRPI0406913B1 (pt) 2016-03-01
ES2415660T3 (es) 2013-07-26
SI1592402T1 (sl) 2013-08-30
WO2004066925B1 (en) 2004-12-09
RU2362546C2 (ru) 2009-07-27
JP2007525413A (ja) 2007-09-06
DK1592402T3 (da) 2013-06-24
CN1741787A (zh) 2006-03-01
WO2004066925A2 (en) 2004-08-12
NZ541753A (en) 2008-12-24
AU2004207498B2 (en) 2008-10-30
UA84140C2 (ru) 2008-09-25
RU2005126729A (ru) 2006-03-10
AR042902A1 (es) 2005-07-06
BRPI0406913A (pt) 2006-01-03
CA2512988A1 (en) 2004-08-12
CN103169655A (zh) 2013-06-26
JP5371187B2 (ja) 2013-12-18
EP1592402B1 (en) 2013-03-20
PT1592402E (pt) 2013-06-25
BRPI0406913B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
NO20053681L (no) Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav
CY1107975T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου με χημικη συγγενεια προς τον υποδοχεα orl1
NO20062082L (no) Pellets inneholdende venlafaksinhydroklorid
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
CY1114616T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
NO20053846L (no) Fremgangsmate for a modifisere legemiddel-krystalldannelse
CY2014042I2 (el) Γλυκοπυρανοζυλο-υποκατεστημενα παραγωγα βενζολιου, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδος για την παραγωγη τους
AR042472A1 (es) Preparaciones de liberacion controlada que comprenden tramadol y topiramato
BRPI0511072A (pt) derivados de alquinila como moduladores dos receptores de glutamato metabotróbico
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
NO2012017I1 (no) Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen.
EA200501586A1 (ru) Фармацевтические продукты
NO20032734L (no) Nye 1,2-difenylazetidinoner, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og anvendelse av disse forbehandling av sykdommer fra lipidstoffskiftet
JP2010529999A5 (no)
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
PE20060500A1 (es) Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
NO20054006D0 (no) Cykliske ureaderivater, fremstillingsfremgangsmate derav og farmasoytisk anvendelse av samme som kinaseinhibitorer
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
BRPI0413353A (pt) composição farmacêutica contendo droga solúvel em água
NO20072290L (no) Organiske forbindelser.
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
DK1838315T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til fremstilling heraf, deres anvendelse som medikament samt medikamenter indeholdende dem
NO20045504L (no) Substituerte tiofener, fremgangsmate for fremstilling, deres anvendelse som medikament eller diagnostisk middel samt et medikament inneholdende disse

Legal Events

Date Code Title Description
MK1K Patent expired